Novel compounds

The present invention discloses novel compounds inhibiting LRRK2 kinase activity, preparation processes thereof, compositions containing them, as well as use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.

Saved in:
Bibliographic Details
Main Authors PHILPS OLIVER JAMES, BAMBOROUGH PAUL, EATHERTON ANDREW JOHN, ANDREOTTI DANIELE, JANDU KARAMJIT SINGH, NICHOLS PAULA LOUISE
Format Patent
LanguageEnglish
Published 21.01.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses novel compounds inhibiting LRRK2 kinase activity, preparation processes thereof, compositions containing them, as well as use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.
Bibliography:Application Number: CN201410456758